Lee Ainslie's GUTS Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 331,234 shares of Fractyl Health, Inc. (GUTS) worth $3.16 M, representing 0.03% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in GUTS, demonstrating sustained confidence in this investment. Largest reduction occurred in Q1 2026, reducing 22,807 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Fractyl Health (GUTS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fractyl Health (GUTS) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -22,807 | Reduce 6.44% | 331,234 | $5.49 |
| Q3 2024 | -515 | Reduce 0.15% | 354,041 | $30.36 |
| Q1 2024 | +4.25 M | New Buy | 354,556 | $88.80 |
Lee Ainslie's Fractyl Health Investment FAQs
Lee Ainslie first purchased Fractyl Health, Inc. (GUTS) in Q1 2024, acquiring 354,556 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Fractyl Health, Inc. (GUTS) for 10 quarters since Q1 2024.
Lee Ainslie's largest addition to Fractyl Health, Inc. (GUTS) was in Q1 2024, adding 354,556 shares worth $31.48 M.
According to the latest 13F filing for Q2 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 331,234 shares of Fractyl Health, Inc. (GUTS), valued at approximately $3.16 M.
As of the Q2 2026 filing, Fractyl Health, Inc. (GUTS) represents approximately 0.03% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Fractyl Health, Inc. (GUTS) was 354,556 shares, as reported at the end of Q1 2024.